Report: Zhonghui Biotech-B (2627.HK) Exceeds 4000-Fold Oversubscription, Becomes Third-Largest IPO of the Year! 195,000 People Subscribe to Zhonghui Biotech, Raising Up to HK$5.18 Billion
Globe Report August 6th ｜ Vaccine company Zhonghui Biotech-B (2627.HK) has ended its subscription today at noon, with news emerging that the public offering part of Zhonghui Biotech\'s IPO has ac